Phoenix Financial Ltd., a registered investment adviser, initiated a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) during Q4 2025, according to its most…
Phoenix Financial Ltd., a registered investment adviser, initiated a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 41,087,131 shares of the Healthcare company, valued at approximately $1.3B as of the filing date.
Teva Pharmaceutical Industries Limited's stock currently trades at $34.83 with a market capitalization of $34.6B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NYSE · TEVA
$36.05
Down: -$0.39 · -1.07%
Live quote updated
Keep reading
institutional ·
institutional ·
sec_filing ·
institutional ·
